Project: Cellular Immune Phenotype in Patients with Severe COVID Disease Before and After COVID-19 Treatment [Funder: NSHA Research & Innovation, Dalhousie Medical Research Foundation, QEII Health Sciences Centre Foundation, IWK Foundation, DGHF, RNS]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Other Funders (Canada)Principal Investigator
Dr Lisa Barrett Lisa BarrettResearch Location
CanadaLead Research Institution
Dalhousie UniversityResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
This study aims to better understand COVID-19 immune disruption and reversibility by examining global and SARS-CoV-2 specific immune dysregulation before, during and after therapy.